Spire Healthcare Group (LON:SPI) Hits New 12-Month Low - Should You Sell?

Spire Healthcare Group plc (LON:SPI - Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 214.50 ($2.79) and last traded at GBX 215 ($2.80), with a volume of 1016819 shares. The stock had previously closed at GBX 217 ($2.82).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 300 ($3.91) price target on shares of Spire Healthcare Group in a report on Tuesday, September 17th.

Spire Healthcare Group Price Performance

The firm has a market cap of £878.31 million, a PE ratio of 3,107.14, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The stock's fifty day moving average price is GBX 233.33 and its 200-day moving average price is GBX 242.79. The company has a debt-to-equity ratio of 169.51, a current ratio of 0.70 and a quick ratio of 0.74.

Insider Transactions at Spire Healthcare Group

In other Spire Healthcare Group news, insider Justin Ash bought 21,100 shares of the company's stock in a transaction dated Tuesday, September 17th. The stock was acquired at an average price of GBX 236 ($3.07) per share, with a total value of £49,796 ($64,821.66). Insiders own 34.71% of the company's stock.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.